{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:42:17Z","timestamp":1777488137397,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T00:00:00Z","timestamp":1507075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K08EY0123998"],"award-info":[{"award-number":["K08EY0123998"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Career development award"],"award-info":[{"award-number":["Career development award"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Washington Department of Medicine De-identified Clinical Data Repository (DCDR) Observational Research Pilot Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12348-017-0137-0","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T12:10:27Z","timestamp":1507119027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tuberculous uveitis: association between anti-tuberculous therapy and clinical response in a non-endemic country"],"prefix":"10.1186","volume":"7","author":[{"given":"Kristina L.","family":"Bajema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaivon","family":"Pakzad-Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hawn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-811X","authenticated-orcid":false,"given":"Kathryn L.","family":"Pepple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,4]]},"reference":[{"key":"137_CR1","unstructured":"World Health Organization. Tuberculosis. Available at: \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/\n                    \n                  . Accessed March 24, 2017"},{"key":"137_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2014. Atlanta: USA Department of Health and Human Services, CDC; 2015."},{"issue":"1","key":"137_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531","volume":"101","author":"M Ang","year":"2017","unstructured":"Ang M, Chee SP (2017) Controversies in ocular tuberculosis. Br J Ophthalmol 101(1):6\u20139","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"137_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149(3):177\u2013184","journal-title":"Ann Intern Med"},{"issue":"4","key":"137_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","volume":"157","author":"NR La Distia","year":"2014","unstructured":"La Distia NR, van Velthoven ME, Ten Dam-van Loon NH et al (2014) Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol 157(4):754\u2013761","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"137_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ajo.2014.06.020","volume":"158","author":"L Caspers","year":"2014","unstructured":"Caspers L, Makhoul D, Ebraert H, Michel O, Willermain F (2014) Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol 158(3):646\u2013647","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"137_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10792-012-9588-3","volume":"32","author":"TI Kuznetcova","year":"2012","unstructured":"Kuznetcova TI, Sauty A, Herbort CP (2012) Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol 32(5):499\u2013506","journal-title":"Int Ophthalmol"},{"issue":"5","key":"137_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","volume":"61","author":"AR Kee","year":"2016","unstructured":"Kee AR, Gonzalez-Lopez JJ, Al-Hity A et al (2016) Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis. Surv Ophthalmol 61(5):628\u2013653","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"137_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140(3):509\u2013516","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"137_CR10","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid P, Dorman SE, Alipanah N et al (2016) Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 63(7):e147\u2013ee95","journal-title":"Clin Infect Dis"},{"key":"137_CR11","unstructured":"World Health Organization (WHO). Use of high burden country lists for TB by WHO in the post-2015 era. Geneva: WHO; 2015."},{"issue":"6","key":"137_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00006982-199515060-00001","volume":"15","author":"J Biswas","year":"1995","unstructured":"Biswas J, Madhavan HN, Gopal L, Badrinath SS (1995) Intraocular tuberculosis. Clinicopathologic study of five cases. Retina 15(6):461\u2013468","journal-title":"Retina"},{"issue":"4","key":"137_CR13","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ophtha.2010.08.011","volume":"118","author":"KJ Wroblewski","year":"2011","unstructured":"Wroblewski KJ, Hidayat AA, Neafie RC, Rao NA, Zapor M (2011) Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology 118(4):772\u2013777","journal-title":"Ophthalmology"},{"issue":"6","key":"137_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA (2007) Intraocular tuberculosis--an update. Surv Ophthalmol 52(6):561\u2013587","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"137_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","volume":"96","author":"M Ang","year":"2012","unstructured":"Ang M, Hedayatfar A, Wong W, Chee SP (2012) Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol 96(3):332\u2013336","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"137_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/09273948.2014.986584","volume":"23","author":"R Agrawal","year":"2015","unstructured":"Agrawal R, Gupta B, Gonzalez-Lopez JJ et al (2015) The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm 23(1):40\u201346","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"137_CR17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","volume":"131","author":"SS Patel","year":"2013","unstructured":"Patel SS, Saraiya NV, Tessler HH, Goldstein DA (2013) Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol 131(6):752\u2013758","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"137_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","volume":"146","author":"R Bansal","year":"2008","unstructured":"Bansal R, Gupta A, Gupta V, Dogra MR, Bambery P, Arora SK (2008) Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis. Am J Ophthalmol 146(5):772\u2013779","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-017-0137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-017-0137-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-017-0137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:45:20Z","timestamp":1589651120000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-017-0137-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,4]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1186\/s12348-017-0137-0","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,4]]},"assertion":[{"value":"30 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the University of Washington Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"19"}}